1 State Key Laboratory of Cancer Biology and Experimental Teaching Center of Basic Medicine, Fourth Military Medical University , Xi'an, China .
2 Department of Pain Treatment, Tangdu Hospital, Fourth Military Medical University , Xi'an, China .
Antioxid Redox Signal. 2018 Apr 20;28(12):1120-1136. doi: 10.1089/ars.2017.6990. Epub 2017 Nov 1.
Levels of the mitochondrial calcium uniporter regulator 1 (MCUR1) increases during development of hepatocellular carcinoma (HCC). However, mechanisms of how mitochondrial Ca homeostasis is modulated and its function remain limited in cancers.
MCUR1 was frequently upregulated in HCC cells to enhance the Ca uptake into mitochondria in an MCU-dependent manner, which significantly facilitated cell survival by inhibiting mitochondria-dependent intrinsic apoptosis and promoting proliferation of HCC cells, and thus led to poor prognosis. In vivo assay confirmed these results, indicating that overexpressed MCUR1 notably decreased the fraction of terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)-positive cells and increased the positive Ki67 staining in xenograft tumors, while reduced MCUR1 expression was associated with impaired growth capacity of HCC cells in nude mice. The survival advantage conferred by MCUR1-mediated mitochondrial Ca uptake was majorly caused by elevated production of mitochondrial reactive oxygen species and subsequent AKT/MDM2- induced P53 degradation, which regulated the expression level of apoptosis-related molecules and cell cycle-related molecules. Treatment of mitochondrial Ca-buffering protein parvalbumin remarkably inhibited the growth of HCC cells. Conclusions and Innovation: Our study provides evidence supporting a possible tumor-promoting role for MCUR1-mediated mitochondrial Ca uptake and uncovers a mechanistic understanding that links change of mitochondrial Ca homeostasis to cancer cell survival, which suggests a potential novel therapeutic target for HCC. Antioxid. Redox Signal. 28, 1120-1136.
线粒体钙单向转运体调节剂 1(MCUR1)的水平在肝细胞癌(HCC)的发展过程中增加。然而,线粒体 Ca 动态平衡如何被调节及其功能在癌症中的机制仍然有限。
MCUR1 在 HCC 细胞中频繁上调,以依赖 MCU 的方式增强线粒体的 Ca 摄取,这通过抑制线粒体依赖性内在凋亡和促进 HCC 细胞增殖显著促进细胞存活,从而导致预后不良。体内实验证实了这些结果,表明过表达的 MCUR1 明显减少了末端脱氧核苷酸转移酶 dUTP 缺口末端标记(TUNEL)阳性细胞的分数,并增加了异种移植瘤中 Ki67 的阳性染色,而降低的 MCUR1 表达与裸鼠中 HCC 细胞生长能力受损有关。MCUR1 介导的线粒体 Ca 摄取赋予的生存优势主要是由于线粒体活性氧的产生增加和随后 AKT/MDM2 诱导的 P53 降解所致,这调节了凋亡相关分子和细胞周期相关分子的表达水平。线粒体 Ca 缓冲蛋白 parvalbumin 的治疗显著抑制了 HCC 细胞的生长。
我们的研究提供了证据支持 MCUR1 介导的线粒体 Ca 摄取可能具有促进肿瘤的作用,并揭示了一种机制理解,将线粒体 Ca 动态平衡的变化与癌细胞存活联系起来,这为 HCC 提供了一个潜在的新的治疗靶点。抗氧化。氧化还原信号。28, 1120-1136。